Skip to main content
Published in: AIDS and Behavior 6/2024

25-04-2024 | Human Immunodeficiency Virus | Editorial

Expanding the Scope of AIDS and Behavior: Behavioral Infectiology

Author: Seth C. Kalichman

Published in: AIDS and Behavior | Issue 6/2024

Login to get access


For nearly three decades, AIDS and Behavior has strived to publish high-impact social and behavioral research on every facet of the HIV pandemic. From its start, our journal has focused attention on understanding the social and behavioral dynamics of HIV transmission, risk reduction, testing and treatment [1]. As HIV prevention interventions emerged and diversified, so too did antiretroviral therapies, pushing AIDS and Behavior in new directions. Contributors and readers of AIDS and Behavior stand at the forefront in the fight against HIV, with undeniable progress toward ending AIDS. Still, with 39 million people living with HIV worldwide and more than a million new HIV infections each year, we know that our work is not done. AIDS and Behavior will therefore continue to advance research to end HIV. …
Expanding the Scope of AIDS and Behavior: Behavioral Infectiology
Seth C. Kalichman
Publication date
Springer US
Published in
AIDS and Behavior / Issue 6/2024
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254

Other articles of this Issue 6/2024

AIDS and Behavior 6/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare